Epigenetic control of highly homologous killer Ig-like receptor gene alleles

Journal of Immunology

Volumn 175, Issue 9, 2005, Pages 5966-5974

  Chan, Huei Wei ^a   Miller, Jeffrey S ^b   Moore, Mikel B ^a   Lutz, Charles T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; DNA METHYLTRANSFERASE INHIBITOR; HISTONE H3; HISTONE H3 LYSINE 4; HISTONE H4; KILLER IMMUNOGLOBULIN LIKE RECEPTOR PROTEIN; METHYLTRANSFERASE INHIBITOR; PROTEIN; RECEPTOR PROTEIN; RNA; UNCLASSIFIED DRUG;

ACETYLATION; ALLELE; ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CPG ISLAND; DNA HISTONE INTERACTION; DNA HYPOMETHYLATION; DNA METHYLATION; ENZYME INHIBITION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; KIR GENE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR GENE; STOCHASTIC MODEL; TRANSCRIPTION REGULATION;

EID: 27144509642     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.9.5966     Document Type: Article

References (41)

1. Fry, C. J., and C. L. Peterson. 2002. Transcription: unlocking the gates to gene expression. Science 295: 1847-1848.
2. Smale, S. T. 2003. The establishment and maintenance of lymphocyte identity through gene silencing. Nat. Immunol. 4: 607-615.
3. Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16: 6-21.
4. Su, R. C., K. E. Brown, S. Saaber, A. G. Fisher, M. Merkenschlager, and S. T. Smale. 2004. Dynamic assembly of silent chromatin during thymocyte maturation. Nat. Genet. 36: 502-506.
5. Heard, E., C. Rougeulle, D. Arnaud, P. Avner, C. D. Allis, and D. L. Spector. 2001. Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 107: 727-738.
6. Lock, L. F., N. Takagi, and G. R. Martin. 1987. Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation. Cell 48: 39-46.
7. Fahrner, J. A., S. Eguchi, J. G. Herman, and S. B. Baylin. 2002. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62: 7213-7218.
8. Stirzaker, C., J. Z. Song, B. Davidson, and S. J. Clark. 2004. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64: 3871-3877.
9. Carrington, M., and P. Norman. 2003. The KIR Gene Cluster. National Library of Medicine (U.S.), National Center for Biotechnology Information, Bethesda.
10. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
11. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97: 4778-4783.
12. Chan, H. W., Z. B. Kurago, C. A. Stewart, M. J. Wilson, M. P. Martin, B. E. Mace, M. Carrington, J. Trowsdale, and C. T. Lutz. 2003. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 197: 245-255.
13. Lutz, C. T., and Z. B. Kurago. 1999. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. Cancer Res. 59: 5793-5799.
14. + T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J. Immunol. 159: 1844-1852.
15. Miller, J. S., and V. McCullar. 2001. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood 98: 705-713.
16. Lanigan, T. M., and A. F. Russe. 1997. Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J. Biol. Chem. 272: 18316-18324.
17. Weinmann, A. S., S. M. Bartley, T. Zhang, M. Q. Zhang, and P. J. Farnham. 2001. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell. Biol. 21: 6820-6832.
18. Stewart, C. A., J. Van Bergen, and J. Trowsdale. 2003. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 170: 6073-6081.
19. Santourlidis, S., H. I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg. 2002. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169: 4253-4261.
20. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP-12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707.
21. Smith, C. L., and G. L. Hager. 1997. Transcriptional regulation of mammalian genes in vivo: a tale of two templates. J. Biol. Chem. 272: 27493-27496.
22. Robertson, K. D., and R. F. Ambinder. 1997. Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter. J. Virol. 71: 6445-6454.
23. Takai, D., and P. A. Jones. 2002. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 99: 3740-3745.
24. Flatau, E., E. Bogenmann, and P. A. Jones. 1983. Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants. Cancer Res. 43: 4901-4905.
25. Santos Rosa, H., R. Schneider, A. J. Bannister, J. Sherriff, B. E. Bernstein, N. C. Emre, S. L. Schreiber, J. Mellor, and T. Kouzarides. 2002. Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411.
26. Schneider, R., A. J. Bannister, F. A. Myers, A. W. Thorne, C. Crane Robinson, and T. Kouzarides. 2004. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6: 73-77.
27. Futscher, B. W., M. M. Oshiro, R. J. Wozniak, N. Holtan, C. L. Hanigan, H. Duan, and F. E. Domann. 2002. Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 31: 175-179.
28. Mutskov, V., and G. Felsenfeld. 2004. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 23: 138-149.
29. Bachman, K. E., B. H. Park, I. Rhee, H. Rajagopalan, J. G. Herman, S. B. Baylin, K. W. Kinzler, and B. Vogelstein. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89-95.
30. Rountree, M. R., K. E. Bachman, and S. B. Baylin. 2000. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 25: 269-277.
31. Fuks, F., W. A. Burgers, A. Brehm, L. Hughes-Davies, and T. Kouzarides. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24: 88-91.
32. Nan, X., H.-H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.
33. Trompeter, H.-I., N. Gómez-Lozano, S. Santourlidis, B. Eisermann, P. Wernet, C. Vilches, and M. Uhrberg. 2005. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J. Immunol. 174: 4135-4143.
34. Van Bergen, J., C. A. Stewart, P. J. van den Elsen, and J. Trowsdale. 2005. Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur. J. Immunol. 35: 2191-2199.
35. Xu, J., A. N. Vallejo, Y. Jiang, C. M. Weyand, and J. J. Goronzy. 2005. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J. Biol. Chem. 280: 24277-24285.
36. Shilling, H. G., N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham. 2002. Genetic control of human NK cell repertoire. J. Immunol. 169: 239-247.
37. Saleh, A., G. E. Davies, V. Pascal, P. W. Wright, D. L. Hodge, E. H. Cho, S. J. Lockett, M. Abshari, and S. K. Anderson. 2004. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 21: 55-66.
38. Bruniquel, D., and R. H. Schwartz. 2003. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4: 235-240.
39. Hsieh, C. L. 1999. Evidence that protein binding specifies sites of DNA demethylation. Mol. Cell. Biol. 19: 46-56.
40. Rajagopalan, S., and E. O. Long. 2005. Understanding how combinations of HLA and KIR genes influence disease. J. Exp. Med. 201: 1025-1029.
41. Snyder, M. R., C. M. Weyand, and J. J. Goronzy. 2004. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 25: 25-32.